 | • レポートコード：QY2112C03907 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は薬理学的解毒剤の世界市場の現状について調査・分析し、2027年までの市場を予測しました。薬理学的解毒剤の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（注射、錠剤、その他）、用途別市場規模（農薬中毒、重金属中毒、動物咬傷中毒、シアン化物中毒、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・薬理学的解毒剤の世界市場概要 ・メーカー別の競争状況、市場シェア ・薬理学的解毒剤の種類別市場規模：注射、錠剤、その他 ・薬理学的解毒剤の用途別市場規模：農薬中毒、重金属中毒、動物咬傷中毒、シアン化物中毒、その他 ・北米の薬理学的解毒剤市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの薬理学的解毒剤市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの薬理学的解毒剤市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の薬理学的解毒剤市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの薬理学的解毒剤市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Roche、Pfizer、Bayer、Johnson & Johnson、Novartis、Eli Lilly、Teva、Boehringer Ingelheim、Mylan、Fresenius Kabi、Baxter、Furen Pharmaceutical、GSK、Viatris ・薬理学的解毒剤のバリューチェーン・販売チャネル分析 ・薬理学的解毒剤の世界市場動向 |
A drug that has the opposite effect on the body from that caused by a poisonous or toxic substance.
Market Analysis and Insights: Global Pharmacological Antidotes Market
The global Pharmacological Antidotes market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Pharmacological Antidotes Scope and Segment
Pharmacological Antidotes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacological Antidotes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Injection
Tablet
Others
Segment by Application
Pesticide Poisoning
Heavy Metal Poisoning
Animal Bites Poisoning
Cyanide Poisoning
Others
By Company
Roche
Pfizer
Bayer
Johnson & Johnson
Novartis
Eli Lilly
Teva
Boehringer Ingelheim
Mylan
Fresenius Kabi
Baxter
Furen Pharmaceutical
GSK
Viatris
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Pharmacological Antidotes Product Introduction
1.2 Market by Type
1.2.1 Global Pharmacological Antidotes Market Size Growth Rate by Type
1.2.2 Injection
1.2.3 Tablet
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pharmacological Antidotes Market Size Growth Rate by Application
1.3.2 Pesticide Poisoning
1.3.3 Heavy Metal Poisoning
1.3.4 Animal Bites Poisoning
1.3.5 Cyanide Poisoning
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pharmacological Antidotes Sales Estimates and Forecasts 2016-2027
2.2 Global Pharmacological Antidotes Revenue Estimates and Forecasts 2016-2027
2.3 Global Pharmacological Antidotes Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Pharmacological Antidotes Regions by Sales
2.4.1 Global Top Pharmacological Antidotes Regions by Sales (2016-2021)
2.4.2 Global Top Pharmacological Antidotes Regions by Sales (2022-2027)
2.5 Global Top Pharmacological Antidotes Regions by Revenue
2.5.1 Global Top Pharmacological Antidotes Regions by Revenue (2016-2021)
2.5.2 Global Top Pharmacological Antidotes Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pharmacological Antidotes Sales by Manufacturers
3.1.1 Global Top Pharmacological Antidotes Manufacturers by Sales (2016-2021)
3.1.2 Global Top Pharmacological Antidotes Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Pharmacological Antidotes Sales in 2020
3.2 Global Pharmacological Antidotes Revenue by Manufacturers
3.2.1 Global Top Pharmacological Antidotes Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Pharmacological Antidotes Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Pharmacological Antidotes Revenue in 2020
3.3 Global Pharmacological Antidotes Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pharmacological Antidotes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pharmacological Antidotes Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharmacological Antidotes Sales by Type
4.1.1 Global Pharmacological Antidotes Historical Sales by Type (2016-2021)
4.1.2 Global Pharmacological Antidotes Forecasted Sales by Type (2022-2027)
4.1.3 Global Pharmacological Antidotes Sales Market Share by Type (2016-2027)
4.2 Global Pharmacological Antidotes Revenue by Type
4.2.1 Global Pharmacological Antidotes Historical Revenue by Type (2016-2021)
4.2.2 Global Pharmacological Antidotes Forecasted Revenue by Type (2022-2027)
4.2.3 Global Pharmacological Antidotes Revenue Market Share by Type (2016-2027)
4.3 Global Pharmacological Antidotes Price by Type
4.3.1 Global Pharmacological Antidotes Price by Type (2016-2021)
4.3.2 Global Pharmacological Antidotes Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Pharmacological Antidotes Sales by Application
5.1.1 Global Pharmacological Antidotes Historical Sales by Application (2016-2021)
5.1.2 Global Pharmacological Antidotes Forecasted Sales by Application (2022-2027)
5.1.3 Global Pharmacological Antidotes Sales Market Share by Application (2016-2027)
5.2 Global Pharmacological Antidotes Revenue by Application
5.2.1 Global Pharmacological Antidotes Historical Revenue by Application (2016-2021)
5.2.2 Global Pharmacological Antidotes Forecasted Revenue by Application (2022-2027)
5.2.3 Global Pharmacological Antidotes Revenue Market Share by Application (2016-2027)
5.3 Global Pharmacological Antidotes Price by Application
5.3.1 Global Pharmacological Antidotes Price by Application (2016-2021)
5.3.2 Global Pharmacological Antidotes Price Forecast by Application (2022-2027)
6 North America
6.1 North America Pharmacological Antidotes Market Size by Type
6.1.1 North America Pharmacological Antidotes Sales by Type (2016-2027)
6.1.2 North America Pharmacological Antidotes Revenue by Type (2016-2027)
6.2 North America Pharmacological Antidotes Market Size by Application
6.2.1 North America Pharmacological Antidotes Sales by Application (2016-2027)
6.2.2 North America Pharmacological Antidotes Revenue by Application (2016-2027)
6.3 North America Pharmacological Antidotes Market Size by Country
6.3.1 North America Pharmacological Antidotes Sales by Country (2016-2027)
6.3.2 North America Pharmacological Antidotes Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pharmacological Antidotes Market Size by Type
7.1.1 Europe Pharmacological Antidotes Sales by Type (2016-2027)
7.1.2 Europe Pharmacological Antidotes Revenue by Type (2016-2027)
7.2 Europe Pharmacological Antidotes Market Size by Application
7.2.1 Europe Pharmacological Antidotes Sales by Application (2016-2027)
7.2.2 Europe Pharmacological Antidotes Revenue by Application (2016-2027)
7.3 Europe Pharmacological Antidotes Market Size by Country
7.3.1 Europe Pharmacological Antidotes Sales by Country (2016-2027)
7.3.2 Europe Pharmacological Antidotes Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pharmacological Antidotes Market Size by Type
8.1.1 Asia Pacific Pharmacological Antidotes Sales by Type (2016-2027)
8.1.2 Asia Pacific Pharmacological Antidotes Revenue by Type (2016-2027)
8.2 Asia Pacific Pharmacological Antidotes Market Size by Application
8.2.1 Asia Pacific Pharmacological Antidotes Sales by Application (2016-2027)
8.2.2 Asia Pacific Pharmacological Antidotes Revenue by Application (2016-2027)
8.3 Asia Pacific Pharmacological Antidotes Market Size by Region
8.3.1 Asia Pacific Pharmacological Antidotes Sales by Region (2016-2027)
8.3.2 Asia Pacific Pharmacological Antidotes Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pharmacological Antidotes Market Size by Type
9.1.1 Latin America Pharmacological Antidotes Sales by Type (2016-2027)
9.1.2 Latin America Pharmacological Antidotes Revenue by Type (2016-2027)
9.2 Latin America Pharmacological Antidotes Market Size by Application
9.2.1 Latin America Pharmacological Antidotes Sales by Application (2016-2027)
9.2.2 Latin America Pharmacological Antidotes Revenue by Application (2016-2027)
9.3 Latin America Pharmacological Antidotes Market Size by Country
9.3.1 Latin America Pharmacological Antidotes Sales by Country (2016-2027)
9.3.2 Latin America Pharmacological Antidotes Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pharmacological Antidotes Market Size by Type
10.1.1 Middle East and Africa Pharmacological Antidotes Sales by Type (2016-2027)
10.1.2 Middle East and Africa Pharmacological Antidotes Revenue by Type (2016-2027)
10.2 Middle East and Africa Pharmacological Antidotes Market Size by Application
10.2.1 Middle East and Africa Pharmacological Antidotes Sales by Application (2016-2027)
10.2.2 Middle East and Africa Pharmacological Antidotes Revenue by Application (2016-2027)
10.3 Middle East and Africa Pharmacological Antidotes Market Size by Country
10.3.1 Middle East and Africa Pharmacological Antidotes Sales by Country (2016-2027)
10.3.2 Middle East and Africa Pharmacological Antidotes Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Roche Pharmacological Antidotes Product Description
11.1.5 Roche Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pfizer Pharmacological Antidotes Product Description
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Bayer Pharmacological Antidotes Product Description
11.3.5 Bayer Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Johnson & Johnson Pharmacological Antidotes Product Description
11.4.5 Johnson & Johnson Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Novartis Pharmacological Antidotes Product Description
11.5.5 Novartis Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Corporation Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Eli Lilly Pharmacological Antidotes Product Description
11.6.5 Eli Lilly Recent Developments
11.7 Teva
11.7.1 Teva Corporation Information
11.7.2 Teva Overview
11.7.3 Teva Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Teva Pharmacological Antidotes Product Description
11.7.5 Teva Recent Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Corporation Information
11.8.2 Boehringer Ingelheim Overview
11.8.3 Boehringer Ingelheim Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Boehringer Ingelheim Pharmacological Antidotes Product Description
11.8.5 Boehringer Ingelheim Recent Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Overview
11.9.3 Mylan Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Mylan Pharmacological Antidotes Product Description
11.9.5 Mylan Recent Developments
11.10 Fresenius Kabi
11.10.1 Fresenius Kabi Corporation Information
11.10.2 Fresenius Kabi Overview
11.10.3 Fresenius Kabi Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Fresenius Kabi Pharmacological Antidotes Product Description
11.10.5 Fresenius Kabi Recent Developments
11.11 Baxter
11.11.1 Baxter Corporation Information
11.11.2 Baxter Overview
11.11.3 Baxter Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Baxter Pharmacological Antidotes Product Description
11.11.5 Baxter Recent Developments
11.12 Furen Pharmaceutical
11.12.1 Furen Pharmaceutical Corporation Information
11.12.2 Furen Pharmaceutical Overview
11.12.3 Furen Pharmaceutical Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Furen Pharmaceutical Pharmacological Antidotes Product Description
11.12.5 Furen Pharmaceutical Recent Developments
11.13 GSK
11.13.1 GSK Corporation Information
11.13.2 GSK Overview
11.13.3 GSK Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 GSK Pharmacological Antidotes Product Description
11.13.5 GSK Recent Developments
11.14 Viatris
11.14.1 Viatris Corporation Information
11.14.2 Viatris Overview
11.14.3 Viatris Pharmacological Antidotes Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Viatris Pharmacological Antidotes Product Description
11.14.5 Viatris Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pharmacological Antidotes Value Chain Analysis
12.2 Pharmacological Antidotes Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharmacological Antidotes Production Mode & Process
12.4 Pharmacological Antidotes Sales and Marketing
12.4.1 Pharmacological Antidotes Sales Channels
12.4.2 Pharmacological Antidotes Distributors
12.5 Pharmacological Antidotes Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pharmacological Antidotes Industry Trends
13.2 Pharmacological Antidotes Market Drivers
13.3 Pharmacological Antidotes Market Challenges
13.4 Pharmacological Antidotes Market Restraints
14 Key Findings in The Global Pharmacological Antidotes Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Pharmacological Antidotes Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Tablet
Table 4. Major Manufacturers of Others
Table 5. Global Pharmacological Antidotes Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Pharmacological Antidotes Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Pharmacological Antidotes Sales by Region (2016-2021) & (K Units)
Table 8. Global Pharmacological Antidotes Sales Market Share by Region (2016-2021)
Table 9. Global Pharmacological Antidotes Sales by Region (2022-2027) & (K Units)
Table 10. Global Pharmacological Antidotes Sales Market Share by Region (2022-2027)
Table 11. Global Pharmacological Antidotes Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Pharmacological Antidotes Revenue Market Share by Region (2016-2021)
Table 13. Global Pharmacological Antidotes Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Pharmacological Antidotes Revenue Market Share by Region (2022-2027)
Table 15. Global Pharmacological Antidotes Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Pharmacological Antidotes Sales Share by Manufacturers (2016-2021)
Table 17. Global Pharmacological Antidotes Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Pharmacological Antidotes Revenue Share by Manufacturers (2016-2021)
Table 19. Pharmacological Antidotes Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Pharmacological Antidotes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Pharmacological Antidotes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacological Antidotes as of 2020)
Table 22. Pharmacological Antidotes Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pharmacological Antidotes Product Offered
Table 24. Date of Manufacturers Enter into Pharmacological Antidotes Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmacological Antidotes Sales by Type (2016-2021) & (K Units)
Table 27. Global Pharmacological Antidotes Sales by Type (2022-2027) & (K Units)
Table 28. Global Pharmacological Antidotes Sales Share by Type (2016-2021)
Table 29. Global Pharmacological Antidotes Sales Share by Type (2022-2027)
Table 30. Global Pharmacological Antidotes Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Pharmacological Antidotes Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Pharmacological Antidotes Revenue Share by Type (2016-2021)
Table 33. Global Pharmacological Antidotes Revenue Share by Type (2022-2027)
Table 34. Pharmacological Antidotes Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Pharmacological Antidotes Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Pharmacological Antidotes Sales by Application (2016-2021) & (K Units)
Table 37. Global Pharmacological Antidotes Sales by Application (2022-2027) & (K Units)
Table 38. Global Pharmacological Antidotes Sales Share by Application (2016-2021)
Table 39. Global Pharmacological Antidotes Sales Share by Application (2022-2027)
Table 40. Global Pharmacological Antidotes Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Pharmacological Antidotes Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Pharmacological Antidotes Revenue Share by Application (2016-2021)
Table 43. Global Pharmacological Antidotes Revenue Share by Application (2022-2027)
Table 44. Pharmacological Antidotes Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Pharmacological Antidotes Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Pharmacological Antidotes Sales by Type (2016-2021) & (K Units)
Table 47. North America Pharmacological Antidotes Sales by Type (2022-2027) & (K Units)
Table 48. North America Pharmacological Antidotes Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Pharmacological Antidotes Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Pharmacological Antidotes Sales by Application (2016-2021) & (K Units)
Table 51. North America Pharmacological Antidotes Sales by Application (2022-2027) & (K Units)
Table 52. North America Pharmacological Antidotes Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Pharmacological Antidotes Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Pharmacological Antidotes Sales by Country (2016-2021) & (K Units)
Table 55. North America Pharmacological Antidotes Sales by Country (2022-2027) & (K Units)
Table 56. North America Pharmacological Antidotes Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Pharmacological Antidotes Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Pharmacological Antidotes Sales by Type (2016-2021) & (K Units)
Table 59. Europe Pharmacological Antidotes Sales by Type (2022-2027) & (K Units)
Table 60. Europe Pharmacological Antidotes Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Pharmacological Antidotes Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Pharmacological Antidotes Sales by Application (2016-2021) & (K Units)
Table 63. Europe Pharmacological Antidotes Sales by Application (2022-2027) & (K Units)
Table 64. Europe Pharmacological Antidotes Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Pharmacological Antidotes Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Pharmacological Antidotes Sales by Country (2016-2021) & (K Units)
Table 67. Europe Pharmacological Antidotes Sales by Country (2022-2027) & (K Units)
Table 68. Europe Pharmacological Antidotes Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Pharmacological Antidotes Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Pharmacological Antidotes Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Pharmacological Antidotes Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Pharmacological Antidotes Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Pharmacological Antidotes Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Pharmacological Antidotes Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Pharmacological Antidotes Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Pharmacological Antidotes Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Pharmacological Antidotes Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Pharmacological Antidotes Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Pharmacological Antidotes Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Pharmacological Antidotes Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Pharmacological Antidotes Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Pharmacological Antidotes Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Pharmacological Antidotes Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Pharmacological Antidotes Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Pharmacological Antidotes Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Pharmacological Antidotes Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Pharmacological Antidotes Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Pharmacological Antidotes Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Pharmacological Antidotes Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Pharmacological Antidotes Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Pharmacological Antidotes Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Pharmacological Antidotes Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Pharmacological Antidotes Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Pharmacological Antidotes Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Pharmacological Antidotes Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Pharmacological Antidotes Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Pharmacological Antidotes Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Pharmacological Antidotes Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Pharmacological Antidotes Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Pharmacological Antidotes Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Pharmacological Antidotes Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Pharmacological Antidotes Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Pharmacological Antidotes Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Pharmacological Antidotes Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Pharmacological Antidotes Revenue by Country (2022-2027) & (US$ Million)
Table 106. Roche Corporation Information
Table 107. Roche Description and Major Businesses
Table 108. Roche Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Roche Pharmacological Antidotes Product
Table 110. Roche Recent Developments
Table 111. Pfizer Corporation Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Pfizer Pharmacological Antidotes Product
Table 115. Pfizer Recent Developments
Table 116. Bayer Corporation Information
Table 117. Bayer Description and Major Businesses
Table 118. Bayer Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Bayer Pharmacological Antidotes Product
Table 120. Bayer Recent Developments
Table 121. Johnson & Johnson Corporation Information
Table 122. Johnson & Johnson Description and Major Businesses
Table 123. Johnson & Johnson Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Johnson & Johnson Pharmacological Antidotes Product
Table 125. Johnson & Johnson Recent Developments
Table 126. Novartis Corporation Information
Table 127. Novartis Description and Major Businesses
Table 128. Novartis Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Novartis Pharmacological Antidotes Product
Table 130. Novartis Recent Developments
Table 131. Eli Lilly Corporation Information
Table 132. Eli Lilly Description and Major Businesses
Table 133. Eli Lilly Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Eli Lilly Pharmacological Antidotes Product
Table 135. Eli Lilly Recent Developments
Table 136. Teva Corporation Information
Table 137. Teva Description and Major Businesses
Table 138. Teva Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Teva Pharmacological Antidotes Product
Table 140. Teva Recent Developments
Table 141. Boehringer Ingelheim Corporation Information
Table 142. Boehringer Ingelheim Description and Major Businesses
Table 143. Boehringer Ingelheim Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Boehringer Ingelheim Pharmacological Antidotes Product
Table 145. Boehringer Ingelheim Recent Developments
Table 146. Mylan Corporation Information
Table 147. Mylan Description and Major Businesses
Table 148. Mylan Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Mylan Pharmacological Antidotes Product
Table 150. Mylan Recent Developments
Table 151. Fresenius Kabi Corporation Information
Table 152. Fresenius Kabi Description and Major Businesses
Table 153. Fresenius Kabi Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. Fresenius Kabi Pharmacological Antidotes Product
Table 155. Fresenius Kabi Recent Developments
Table 156. Baxter Corporation Information
Table 157. Baxter Description and Major Businesses
Table 158. Baxter Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 159. Baxter Pharmacological Antidotes Product
Table 160. Baxter Recent Developments
Table 161. Furen Pharmaceutical Corporation Information
Table 162. Furen Pharmaceutical Description and Major Businesses
Table 163. Furen Pharmaceutical Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 164. Furen Pharmaceutical Pharmacological Antidotes Product
Table 165. Furen Pharmaceutical Recent Developments
Table 166. GSK Corporation Information
Table 167. GSK Description and Major Businesses
Table 168. GSK Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 169. GSK Pharmacological Antidotes Product
Table 170. GSK Recent Developments
Table 171. Viatris Corporation Information
Table 172. Viatris Description and Major Businesses
Table 173. Viatris Pharmacological Antidotes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 174. Viatris Pharmacological Antidotes Product
Table 175. Viatris Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Pharmacological Antidotes Distributors List
Table 179. Pharmacological Antidotes Customers List
Table 180. Pharmacological Antidotes Market Trends
Table 181. Pharmacological Antidotes Market Drivers
Table 182. Pharmacological Antidotes Market Challenges
Table 183. Pharmacological Antidotes Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmacological Antidotes Product Picture
Figure 2. Global Pharmacological Antidotes Market Share by Type in 2020 & 2027
Figure 3. Injection Product Picture
Figure 4. Tablet Product Picture
Figure 5. Others Product Picture
Figure 6. Global Pharmacological Antidotes Market Share by Application in 2020 & 2027
Figure 7. Pesticide Poisoning
Figure 8. Heavy Metal Poisoning
Figure 9. Animal Bites Poisoning
Figure 10. Cyanide Poisoning
Figure 11. Others
Figure 12. Pharmacological Antidotes Report Years Considered
Figure 13. Global Pharmacological Antidotes Sales 2016-2027 (K Units)
Figure 14. Global Pharmacological Antidotes Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Pharmacological Antidotes Revenue 2016-2027 (US$ Million)
Figure 16. Global Pharmacological Antidotes Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Pharmacological Antidotes Sales Market Share by Region (2016-2021)
Figure 18. Global Pharmacological Antidotes Sales Market Share by Region (2022-2027)
Figure 19. North America Pharmacological Antidotes Sales YoY (2016-2027) & (K Units)
Figure 20. North America Pharmacological Antidotes Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Pharmacological Antidotes Sales YoY (2016-2027) & (K Units)
Figure 22. Europe Pharmacological Antidotes Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Pharmacological Antidotes Sales YoY (2016-2027) & (K Units)
Figure 24. Asia-Pacific Pharmacological Antidotes Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Pharmacological Antidotes Sales YoY (2016-2027) & (K Units)
Figure 26. Latin America Pharmacological Antidotes Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Pharmacological Antidotes Sales YoY (2016-2027) & (K Units)
Figure 28. Middle East & Africa Pharmacological Antidotes Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Pharmacological Antidotes Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Pharmacological Antidotes Revenue in 2020
Figure 31. Pharmacological Antidotes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Pharmacological Antidotes Sales Market Share by Type (2016-2027)
Figure 33. Global Pharmacological Antidotes Revenue Market Share by Type (2016-2027)
Figure 34. Global Pharmacological Antidotes Sales Market Share by Application (2016-2027)
Figure 35. Global Pharmacological Antidotes Revenue Market Share by Application (2016-2027)
Figure 36. North America Pharmacological Antidotes Sales Market Share by Type (2016-2027)
Figure 37. North America Pharmacological Antidotes Revenue Market Share by Type (2016-2027)
Figure 38. North America Pharmacological Antidotes Sales Market Share by Application (2016-2027)
Figure 39. North America Pharmacological Antidotes Revenue Market Share by Application (2016-2027)
Figure 40. North America Pharmacological Antidotes Sales Share by Country (2016-2027)
Figure 41. North America Pharmacological Antidotes Revenue Share by Country (2016-2027)
Figure 42. United States Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 43. Canada Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 44. Europe Pharmacological Antidotes Sales Market Share by Type (2016-2027)
Figure 45. Europe Pharmacological Antidotes Revenue Market Share by Type (2016-2027)
Figure 46. Europe Pharmacological Antidotes Sales Market Share by Application (2016-2027)
Figure 47. Europe Pharmacological Antidotes Revenue Market Share by Application (2016-2027)
Figure 48. Europe Pharmacological Antidotes Sales Share by Country (2016-2027)
Figure 49. Europe Pharmacological Antidotes Revenue Share by Country (2016-2027)
Figure 50. Germany Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 51. France Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 52. U.K. Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 53. Italy Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 54. Russia Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 55. Asia Pacific Pharmacological Antidotes Sales Market Share by Type (2016-2027)
Figure 56. Asia Pacific Pharmacological Antidotes Revenue Market Share by Type (2016-2027)
Figure 57. Asia Pacific Pharmacological Antidotes Sales Market Share by Application (2016-2027)
Figure 58. Asia Pacific Pharmacological Antidotes Revenue Market Share by Application (2016-2027)
Figure 59. Asia Pacific Pharmacological Antidotes Sales Share by Region (2016-2027)
Figure 60. Asia Pacific Pharmacological Antidotes Revenue Share by Region (2016-2027)
Figure 61. China Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 62. Japan Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 63. South Korea Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 64. India Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 65. Australia Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 66. Taiwan Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 67. Indonesia Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 68. Thailand Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 69. Malaysia Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 70. Latin America Pharmacological Antidotes Sales Market Share by Type (2016-2027)
Figure 71. Latin America Pharmacological Antidotes Revenue Market Share by Type (2016-2027)
Figure 72. Latin America Pharmacological Antidotes Sales Market Share by Application (2016-2027)
Figure 73. Latin America Pharmacological Antidotes Revenue Market Share by Application (2016-2027)
Figure 74. Latin America Pharmacological Antidotes Sales Share by Country (2016-2027)
Figure 75. Latin America Pharmacological Antidotes Revenue Share by Country (2016-2027)
Figure 76. Mexico Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 77. Brazil Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 78. Argentina Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 79. Middle East and Africa Pharmacological Antidotes Sales Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Pharmacological Antidotes Revenue Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Pharmacological Antidotes Sales Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Pharmacological Antidotes Revenue Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Pharmacological Antidotes Sales Share by Country (2016-2027)
Figure 84. Middle East and Africa Pharmacological Antidotes Revenue Share by Country (2016-2027)
Figure 85. Turkey Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 86. Saudi Arabia Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 87. UAE Pharmacological Antidotes Revenue (2016-2027) & (US$ Million)
Figure 88. Pharmacological Antidotes Value Chain
Figure 89. Pharmacological Antidotes Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
物理的解毒剤のグローバル市場インサイト・予測（～2027年） Physical antidotes which prevent the absorption of poison into the body. a) Adsorbing: The main example is activated charcoal. b) Coating: A mixture of egg & milk make a coat over the mucosa. c) Dissolving: 10% alcohol or glycine for carbolic acid. Market Analysis and Insights: Global Physical Antid…- 金属射出成形用粉末のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Powders for Metal Injection Moulding Market The global Powders for Metal Injection Moulding market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Powders for Met…
- シアン化水素センサーのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Hydrogen Cyanide Sensor Market The global Hydrogen Cyanide Sensor market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Hydrogen Cyanide Sensor Scope and Segment…
- 乳酸菌注射液のグローバル市場インサイト・予測（～2027年） Lactated Ringer’s Injection is a sterile, non-pyrogenic solution intended for fluid and electrolyte replenishment in single dose containers. May be administered intravenously, subcutaneously or intraperitoneally (except in horses) using aseptic technique. Market Analysis and Insights: Global Lactate…
- テトラデシル硫酸ナトリウム注射のグローバル市場インサイト・予測（～2027年） Sodium Tetradecyl Sulfate Injection is a sclerosing agent. It works by increasing the formation of blood clots and scar tissue inside certain types of veins. This helps decrease dilation of enlarged veins. Market Analysis and Insights: Global Sodium Tetradecyl Sulfate Injection Market The global Sod…